Although how CDC37 acts differently on Akt in mutant and wild-type BRAF colon cancer cells remains unknown, it is unlikely caused by mutations in its gene as all the colon cancer cell lines included in this study harbored wild-type CDC37. Here, AKT1 is linked to colonic neoplasm.